PhotoCure ASA

PHS

Company Profile

  • Business description

    PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.

  • Contact

    Hoffsveien 4
    Oslo0275
    NOR

    T: +47 22062210

    E: [email protected]

    https://www.photocure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    101

Stocks News & Analysis

stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,915.4035.800.40%
CAC 408,258.26142.511.76%
DAX 4025,389.10500.542.01%
Dow JONES (US)50,579.70294.040.58%
FTSE 10010,466.2622.790.22%
HKSE25,606.03219.510.86%
NASDAQ26,343.9750.870.19%
Nikkei 22565,158.191,819.122.87%
NZX 50 Index13,163.43193.151.49%
S&P 5007,473.4727.750.37%
S&P/ASX 2008,692.0035.900.41%
SSE Composite Index4,112.9035.620.87%

Market Movers